Limited data is available for end of life care in hematologic malignancies, moreover with thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow involvement in those diseases or its treatments. Yet, a few studies was interested in, whereas platelet transfusion is the only treatment indicated. As it represent a scarce, limited resource, the ethical principles are in conflict in this setting and there's a lack of recommendation. The final decision is take by the clinician and his patient, but no study exist in representation of the two parts. We provide a qualitative study to understand what this decision is made of.

Inclusion Criteria:

• major patient
• patient with advanced hematological malignancies
• patient transfused in platelet regularly (3 time at least in last month)
• medical practioner, hematologist, prescribing platelet transfusion at least one per week.
• nurse working in hematology, practicing platelet transfusion at lest one peer week.

Exclusion Criteria:

• minor patient
• non communicant patient
• non transfused platelet patient
• non voluntary patient or hematologist or nurses
• non graduated hematologist

Patient with advanced hematological malignancies, transfused in platelet regulary, hematologist's nurses who practice platelet transfusion and hematologist who prescribe the transfusion.

interview will be registered then transcribe on professional computer ans accessible only by the investigator and collaborators.